SEEQUIN 2- hydroquinone liquid 
Vivier Pharma, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Seequin 2

Active Ingredient

Hydroquinone (2%)

Indication

Skin Lightening

Indication

To gradually lighten hyperpigmentation of the skin such as age spots, liver spots, freckles, or other areas of unwanted melanin hyperpigmentation that may occur in pregnancy or from the use of oral contraceptives.

Precautions

For external use only. A mild transient stinging may occur for people with sensitive skin. Do not use on broken or irritated skin. Discontinue use if irritation or rash occurs. Avoid contact with eyes and mucous membranes. In case of contact, rinse thoroughly with water. Do not use on children under 12 years of age. Keep out of reach of children. Avoid use around the eyes and lips.

Precautions

keep away from children.

Directions

Remove and discard solid white cap from bottle and replace with dropper cap. Test for skin sensitivity before using by applying 1 or 2 drops of SEEQUIN™ 2 IDS™ Liquid Gel S-erum * to an area of unbroken skin about 25 mm in diameter. If excessive irritation, rash or other reaction develops within 24 hours, discontinue use. To apply, place 1 to 2 drops of SEEQUIN™ 2 IDS™ Liquid Gel S-erum* in the palm of your hand and use fingertips to apply a thin layer to the affected areas. Use both morning and night or as directed by a physician. Depigmentation is a gradual process and results should be expected within 12 weeks of daily use. Discontinue use if no results are apparent after 8 weeks. To maintain results, use several times per week or as directed by a physician. Limit sun exposure during treatment by using protective clothing or a sunscreen protective agent to avoid re-darkening of the skin. Close dropper cap securely after each use. Store at room temperature (15-25°C / 59-77°F).

Non-Medicinal Ingredients

CITRUS GRANDIS (GRAPEFRUIT) EXTRACT, ETHOXYDIGLYCOL, FRAGRANCE/ PARFUM, L-ASCORBIC ACID USP, PROPYLENE GLYCOL, WATER/EAU.

Principal Display Panel

Seequin2__PackageLabel_PrincipalDisplayPanel

Seequin2__PackageLabel_PrincipalDisplayPanel

SEEQUIN 2 
hydroquinone liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67226-2620
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
GRAPEFRUIT (UNII: O82C39RR8C)  
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
ASCORBIC ACID (UNII: PQ6CK8PD0R)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:67226-2620-31 in 1 BOX
130 mL in 1 BOTTLE, DROPPER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart358A09/01/2013
Labeler - Vivier Pharma, Inc. (250996550)
Establishment
NameAddressID/FEIBusiness Operations
Vivier Pharma, Inc.250996550manufacture(67226-2620)

Revised: 11/2013
Document Id: a39e0e11-37aa-4e3a-a205-2ec1a5fcba3f
Set id: 60807e27-8b3e-42c2-8b69-304c12063946
Version: 2
Effective Time: 20131106
 
Vivier Pharma, Inc.